Will Healthcare See a Boost with Rs 10,000 Crore for Bio Pharma Shakti in Budget 2026-27?
Synopsis
The recent Budget announcement by Finance Minister Nirmala Sitharaman includes a significant allocation of Rs 10,000 crore for the Bio Pharma Shakti scheme. This initiative aims to bolster India's position in the global bio-pharmaceutical sector while addressing pressing health challenges such as non-communicable diseases.
Key Takeaways
Rs 10,000 crore allocated for Bio Pharma Shakti scheme.
Focus on biologics and biosimilar drugs .
Creation of 1 lakh Allied Health Professionals .
Introduction of 1.5 lakh caregivers for elderly care.
Expansion of emergency and trauma centers .
New Delhi, Feb 1 (NationPress) The Finance Minister, Nirmala Sitharaman, revealed an allocation of Rs 10,000 crore for the Bio Pharma Shakti initiative during the Budget presentation for 2026-27. This scheme aims to support the development of biologics and biosimilar drugs, positioning India as a leading global player in the bio-pharmaceutical sector.
In her address, she highlighted that these bio medicines will be instrumental in addressing the increasing prevalence of non-communicable diseases, such as diabetes.
Moreover, the Finance Minister announced the creation of 1 lakh Allied Health Professionals (AHPs) across 10 specializations, including optometry, radiology, and anaesthesia, over the next five years.
Additionally, the government plans to establish 1.5 lakh caregivers for elderly care and programs aligned with the National Skills Qualifications Framework (NSQF).
Further developments include the establishment of more emergency and trauma centers and the construction of mental health institutions similar to NIMHANS.
During her presentation of the 2026-27 Budget, the Finance Minister noted that since the onset of the Modi government, India's economic path has been characterized by fiscal discipline and ongoing growth.
She proposed initiatives across six sectors, focusing on manufacturing, strategic, and frontier sectors, along with healthcare and advanced technology.
Among other initiatives, she emphasized the need to enhance manufacturing in strategic sectors and develop urban economic regions.
Furthermore, the Finance Minister articulated that comprehensive reforms have been undertaken to foster employment, enhance productivity, and accelerate growth. “Over 350 reforms have been implemented, and the 'Reforms Express' is on track; India will continue to stride confidently towards Viksit Bharat, ensuring a balance between ambition and inclusion,” she stated.
Sitharaman emphasized that the Union Budget crafted at Kartivya Bhavan is driven by three kartavya (duties): to expedite and sustain economic growth, meet the aspirations of citizens, and ensure resource accessibility for every family, community, and region.
Point of View
I find the government's commitment to enhancing healthcare through the Bio Pharma Shakti scheme commendable. The initiatives outlined in the Budget reflect a thoughtful approach to addressing the pressing health needs of our population while aiming for a sustainable economic future. It's essential that these plans are executed effectively to truly benefit the citizens of our nation.
NationPress
12 May 2026
Frequently Asked Questions
What is the Bio Pharma Shakti scheme?
The Bio Pharma Shakti scheme is an initiative announced in the Budget 2026-27 aimed at boosting the production of biologics and biosimilar drugs in India.
How much funding has been allocated to the Bio Pharma Shakti scheme?
A funding of Rs 10,000 crore has been allocated for the Bio Pharma Shakti scheme.
What is the significance of this funding?
This funding is intended to position India as a global hub for bio-pharmaceuticals and address the growing healthcare challenges posed by non-communicable diseases.
What other healthcare initiatives were announced?
The budget includes plans to create 1 lakh Allied Health Professionals and 1.5 lakh caregivers, along with the establishment of more emergency and trauma centers.
What are the expected outcomes of these healthcare reforms?
The reforms are expected to enhance healthcare accessibility, improve the quality of medical services, and better manage the increasing burden of chronic diseases.
